نتائج البحث 211-220 من 8206 لعملية البحث عن Lymphoma red flag
... lymphoma patients. Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used.
Scottsdale/Phoenix, Ariz. The purpose of this study is to evaluate a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL) ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
Blood Cancers & Disorders Discussions. roberthall0452. Anyone else have Mantle Cell Lymphoma? 126 Replies Sat, Sep 19, 2026.
The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
Anyone else have Mantle Cell Lymphoma? 124 Replies Thu, Sep 17, 2026.
David J. DiCaudo, M.D.. Pathologist; Dermatologist; Dermatopathologist. Phoenix, AZ. مناطق التركيز: Cutaneous t-cell lymphoma, Sezary syndrome, T ...
Thomas E. Witzig, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. مناطق التركيز: Multiple myeloma, Non-Hodgkin lymphoma, Hodgkin ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.